Why the study?
The effect of implementing intermittent versus continuous fetal heart rate monitoring with Moyo on intrapartum care and neonatal outcomes remained unclear.
Does continuous fetal heart rate monitoring using the Moyo device reduce the time to delivery after abnormal FHR detection and improve neonatal outcomes in laboring women?
Population
1,091 control and 8,687 intervention participants across seven hospitals in Nepal
Comparison
Continuous fetal heart rate monitoring with Moyo vs intermittent monitoring
Design
Prospective observational study
Key result
Continuous fetal heart rate monitoring with Moyo significantly reduced the time from first abnormal fetal heart rate detection to delivery by 66.5 minutes compared to intermittent monitoring.
Authors
Loading...
Non-significant reduction in time to abnormal FHR detection; does not support adoption and leaves efficacy open for further trials.
Observational (n=9,778)
Yes
Does continuous fetal heart rate monitoring using the Moyo device reduce the time to delivery after abnormal FHR detection and improve neonatal outcomes in laboring women?
Mean Difference: -66.5 (95% CI -106.2–-26.8)
Absolute Event Rate: 73% vs 132.2%
p-value: p=0.001
Continuous fetal heart rate monitoring with a portable device reduces the time to delivery following abnormal FHR detection and decreases the need for neonatal resuscitation compared to intermittent monitoring.
Basnet et al. (2026) conducted an observational in Labor (n=9,778). Continuous fetal heart rate monitoring using Moyo vs. Intermittent fetal heart rate monitoring using Moyo was evaluated on Time from first abnormal fetal heart rate detection to delivery (adj.β -66.5 min, 95% CI -106.2 to -26.8, p=0.001). Continuous fetal heart rate monitoring with Moyo significantly reduced the time from first abnormal fetal heart rate detection to delivery by 66.5 minutes compared to intermittent monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: